Frontiers in Cardiovascular Medicine (Jul 2024)

The role of uromodulin in cardiovascular disease: a review

  • Chengqian Chen,
  • Wentao Zhong,
  • Hao Zheng,
  • Gaoying Dai,
  • Wei Zhao,
  • Yushi Wang,
  • Qi Dong,
  • Botao Shen

DOI
https://doi.org/10.3389/fcvm.2024.1417593
Journal volume & issue
Vol. 11

Abstract

Read online

Uromodulin, also referred to as Tamm Horsfall protein (THP), is a renal protein exclusively synthesized by the kidneys and represents the predominant urinary protein under normal physiological conditions. It assumes a pivotal role within the renal system, contributing not only to ion transport and immune modulation but also serving as a critical factor in the prevention of urinary tract infections and kidney stone formation. Emerging evidence indicates that uromodulin may serve as a potential biomarker extending beyond renal function. Recent clinical investigations and Mendelian randomization studies have unveiled a discernible association between urinary regulatory protein levels and cardiovascular events and mortality. This review primarily delineates the intricate relationship between uromodulin and cardiovascular disease, elucidates its predictive utility as a novel biomarker for cardiovascular events, and delves into its involvement in various physiological and pathophysiological facets of the cardiovascular system, incorporating recent advancements in corresponding genetics.

Keywords